National Economy Minister Marton Nagy congratulated the CEOs of Richter and BioTalentum, Gábor Orbán and András Dinnyés, respectively.

Projects designated Ipcei are expected to contribute to European Health Union objectives by delivering innovations addressing diseases for which there are no satisfactory means of prevention or treatment and by increasing the EU's preparedness for emerging health threats. 

Richter's Flow-Kilo-Lab project is focused on a laboratory for flow chemistry technologies with advantages over conventional technologies.

BioTalentum's Cardiabetter project supports the development of drug treatment for diabetes and heart disease.